Other publications in Current drug targets. CNS and neurological disorders

Endocannabinoid metabolic pathways and enzymes.

Published in Dec 01, 2005

Cannabinoids: between neuroprotection and neurotoxicity.

Published in Dec 01, 2005

Endocannabinoids in neuroimmunology and stress.

Published in Dec 01, 2005

Partial QSAR analysis of some selected natural inhibitors of FAAH suggests a working hypothesis for...

Published in Dec 01, 2005

Therapeutic perspectives of inhibitors of endocannabinoid degradation.

Published in Dec 01, 2005